Global Anti-epileptic Drugs for Pediatrics Market Analysis 2015-2019 and Forecast 2020-2025

99S3753080
80 Pages
February 2020
Healthcare

Download Sample Get Discount

Snapshot

The global Anti-epileptic Drugs for Pediatrics market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Anti-epileptic Drugs for Pediatrics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

First Generation

Second Generation

Third Generation

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

Mylan N.V.

Cephalon, Inc.

GlaxoSmithKline plc

Janssen Pharmaceuticals

Novartis AG

Pfizer, Inc.

Sanofi S.A.

UCB Pharma Limited

Sunovion Pharmaceuticals Limited

Valeant Pharmaceuticals International, Inc.

Zogenix

GW Pharmaceuticals

Insys

Zynerba

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Clinic

Hospital

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Contents

1 Industry Overview

1.1 Anti-epileptic Drugs for Pediatrics Industry

Figure Anti-epileptic Drugs for Pediatrics Industry Chain Structure

1.1.1 Overview

1.1.2 Development of Anti-epileptic Drugs for Pediatrics

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of Anti-epileptic Drugs for Pediatrics

1.2.2 Downstream

Table Application Segment of Anti-epileptic Drugs for Pediatrics

Table Global Anti-epileptic Drugs for Pediatrics Market 2015-2025, by Application, in USD Million

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Anti-epileptic Drugs for Pediatrics Market by Type

3.1 By Type

3.1.1 First Generation

Table Major Company List of First Generation

3.1.2 Second Generation

Table Major Company List of Second Generation

3.1.3 Third Generation

Table Major Company List of Third Generation

3.2 Market Size

Table Global Anti-epileptic Drugs for Pediatrics Market 2015-2019, by Type, in USD Million

Figure Global Anti-epileptic Drugs for Pediatrics Market Growth 2015-2019, by Type, in USD Million

Table Global Anti-epileptic Drugs for Pediatrics Market 2015-2019, by Type, in Volume

Figure Global Anti-epileptic Drugs for Pediatrics Market Growth 2015-2019, by Type, in Volume

3.3 Market Forecast

Table Global Anti-epileptic Drugs for Pediatrics Market Forecast 2020-2025, by Type, in USD Million

Table Global Anti-epileptic Drugs for Pediatrics Market Forecast 2020-2025, by Type, in Volume

4 Major Companies List

4.1 Mylan N.V. (Company Profile, Sales Data etc.)

4.1.1 Mylan N.V. Profile

Table Mylan N.V. Overview List

4.1.2 Mylan N.V. Products & Services

4.1.3 Mylan N.V. Business Operation Conditions

Table Business Operation of Mylan N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 Cephalon, Inc. (Company Profile, Sales Data etc.)

4.2.1 Cephalon, Inc. Profile

Table Cephalon, Inc. Overview List

4.2.2 Cephalon, Inc. Products & Services

4.2.3 Cephalon, Inc. Business Operation Conditions

Table Business Operation of Cephalon, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 GlaxoSmithKline plc (Company Profile, Sales Data etc.)

4.3.1 GlaxoSmithKline plc Profile

Table GlaxoSmithKline plc Overview List

4.3.2 GlaxoSmithKline plc Products & Services

4.3.3 GlaxoSmithKline plc Business Operation Conditions

Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 Janssen Pharmaceuticals (Company Profile, Sales Data etc.)

4.4.1 Janssen Pharmaceuticals Profile

Table Janssen Pharmaceuticals Overview List

4.4.2 Janssen Pharmaceuticals Products & Services

4.4.3 Janssen Pharmaceuticals Business Operation Conditions

Table Business Operation of Janssen Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 Novartis AG (Company Profile, Sales Data etc.)

4.5.1 Novartis AG Profile

Table Novartis AG Overview List

4.5.2 Novartis AG Products & Services

4.5.3 Novartis AG Business Operation Conditions

Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.6 Pfizer, Inc. (Company Profile, Sales Data etc.)

4.6.1 Pfizer, Inc. Profile

Table Pfizer, Inc. Overview List

4.6.2 Pfizer, Inc. Products & Services

4.6.3 Pfizer, Inc. Business Operation Conditions

Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.7 Sanofi S.A. (Company Profile, Sales Data etc.)

4.7.1 Sanofi S.A. Profile

Table Sanofi S.A. Overview List

4.7.2 Sanofi S.A. Products & Services

4.7.3 Sanofi S.A. Business Operation Conditions

Table Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.8 UCB Pharma Limited (Company Profile, Sales Data etc.)

4.8.1 UCB Pharma Limited Profile

Table UCB Pharma Limited Overview List

4.8.2 UCB Pharma Limited Products & Services

4.8.3 UCB Pharma Limited Business Operation Conditions

Table Business Operation of UCB Pharma Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.9 Sunovion Pharmaceuticals Limited (Company Profile, Sales Data etc.)

4.9.1 Sunovion Pharmaceuticals Limited Profile

Table Sunovion Pharmaceuticals Limited Overview List

4.9.2 Sunovion Pharmaceuticals Limited Products & Services

4.9.3 Sunovion Pharmaceuticals Limited Business Operation Conditions

Table Business Operation of Sunovion Pharmaceuticals Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.10 Valeant Pharmaceuticals International, Inc. (Company Profile, Sales Data etc.)

4.10.1 Valeant Pharmaceuticals International, Inc. Profile

Table Valeant Pharmaceuticals International, Inc. Overview List

4.10.2 Valeant Pharmaceuticals International, Inc. Products & Services

4.10.3 Valeant Pharmaceuticals International, Inc. Business Operation Conditions

Table Business Operation of Valeant Pharmaceuticals International, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.11 Zogenix (Company Profile, Sales Data etc.)

4.11.1 Zogenix Profile

Table Zogenix Overview List

4.11.2 Zogenix Products & Services

4.11.3 Zogenix Business Operation Conditions

Table Business Operation of Zogenix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.12 GW Pharmaceuticals (Company Profile, Sales Data etc.)

4.12.1 GW Pharmaceuticals Profile

Table GW Pharmaceuticals Overview List

4.12.2 GW Pharmaceuticals Products & Services

4.12.3 GW Pharmaceuticals Business Operation Conditions

Table Business Operation of GW Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

4.13 Insys (Company Profile, Sales Data etc.)

4.13.1 Insys Profile

Table Insys Overview List

4.13.2 Insys Products & Services

4.13.3 Insys Business Operation Conditions

Table Business Operation of Insys (Sales Revenue, Cost, Gross Margin)

4.14 Zynerba (Company Profile, Sales Data etc.)

4.14.1 Zynerba Profile

Table Zynerba Overview List

4.14.2 Zynerba Products & Services

4.14.3 Zynerba Business Operation Conditions

Table Business Operation of Zynerba (Sales Revenue, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global Anti-epileptic Drugs for Pediatrics Sales Revenue 2015-2019, by Company, in USD Million

Table Global Anti-epileptic Drugs for Pediatrics Sales Revenue Share 2015-2019, by Company, in USD Million

Figure Global Anti-epileptic Drugs for Pediatrics Sales Revenue Share in 2019, by Company, in USD Million

Table Global Anti-epileptic Drugs for Pediatrics Sales Volume 2015-2019, by Company, in Volume

Table Global Anti-epileptic Drugs for Pediatrics Sales Volume Share 2015-2019, by Company, in Volume

Figure Global Anti-epileptic Drugs for Pediatrics Sales Volume Share in 2019, by Company, in Volume

5.2 Regional Market by Company

Figure North America Anti-epileptic Drugs for Pediatrics Market Concentration, in 2019

Figure Europe Anti-epileptic Drugs for Pediatrics Market Market Concentration, in 2019

Figure Asia-Pacific Anti-epileptic Drugs for Pediatrics MMarket Concentration, in 2019

Figure South America Anti-epileptic Drugs for Pediatrics Market Concentration, in 2019

Figure Middle East & Africa Anti-epileptic Drugs for Pediatrics Market Concentration, in 2019

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Clinic

Figure Anti-epileptic Drugs for Pediatrics Demand in Clinic, 2015-2019, in USD Million

Figure Anti-epileptic Drugs for Pediatrics Demand in Clinic, 2015-2019, in Volume

6.1.2 Demand in Hospital

Figure Anti-epileptic Drugs for Pediatrics Demand in Hospital, 2015-2019, in USD Million

Figure Anti-epileptic Drugs for Pediatrics Demand in Hospital, 2015-2019, in Volume

6.1.3 Demand in Others

Figure Anti-epileptic Drugs for Pediatrics Demand in Others, 2015-2019, in USD Million

Figure Anti-epileptic Drugs for Pediatrics Demand in Others, 2015-2019, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table Anti-epileptic Drugs for Pediatrics Demand Forecast 2020-2025, by Application, in USD Million

Figure Anti-epileptic Drugs for Pediatrics Market Growth 2020-2025, by Application, in USD Million

Figure Anti-epileptic Drugs for Pediatrics Market Share in 2025, by Application, in USD Million

Table Anti-epileptic Drugs for Pediatrics Demand Forecast 2020-2025, by Application, in Volume

Table Anti-epileptic Drugs for Pediatrics Market Growth 2020-2025, by Application, in Volume

Table Anti-epileptic Drugs for Pediatrics Market Share in 2025, by Application, in Volume

7 Region Operation

7.1 Regional Production

Table Anti-epileptic Drugs for Pediatrics Production 2015-2019, by Region, in USD Million

Table Anti-epileptic Drugs for Pediatrics Production 2015-2019, by Region, in Volume

7.2 Regional Market

Table Global Anti-epileptic Drugs for Pediatrics Market 2015-2019, by Region, in USD Million

Table Global Anti-epileptic Drugs for Pediatrics Market Share 2015-2019, by Region, in USD Million

Table Global Anti-epileptic Drugs for Pediatrics Market 2015-2019, by Region, in Volume

Table Global Anti-epileptic Drugs for Pediatrics Market Share 2015-2019, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America Anti-epileptic Drugs for Pediatrics Market Size and Growth 2015-2019, in USD Million

Figure North America Anti-epileptic Drugs for Pediatrics Market Size and Growth 2015-2019, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Anti-epileptic Drugs for Pediatrics Market Size 2015-2019, by Country, in USD Million

Table North America Anti-epileptic Drugs for Pediatrics Market Size 2015-2019, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe Anti-epileptic Drugs for Pediatrics Market Size and Growth 2015-2019, in USD Million

Figure Europe Anti-epileptic Drugs for Pediatrics Market Size and Growth 2015-2019, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Anti-epileptic Drugs for Pediatrics Market Size 2015-2019, by Country, in USD Million

Table Europe Anti-epileptic Drugs for Pediatrics Market Size 2015-2019, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific Anti-epileptic Drugs for Pediatrics Market Size and Growth 2015-2019, in USD Million

Figure Asia-Pacific Anti-epileptic Drugs for Pediatrics Market Size and Growth 2015-2019, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Anti-epileptic Drugs for Pediatrics Market Size 2015-2019, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America Anti-epileptic Drugs for Pediatrics Market Size and Growth 2015-2019, in USD Million

Figure South America Anti-epileptic Drugs for Pediatrics Market Size and Growth 2015-2019, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Anti-epileptic Drugs for Pediatrics Market Size 2015-2019, by Country, in USD Million

Table South America Anti-epileptic Drugs for Pediatrics Market Size 2015-2019, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa Anti-epileptic Drugs for Pediatrics Market Size and Growth 2015-2019, in USD Million

Figure Middle East & Africa Anti-epileptic Drugs for Pediatrics Market Size and Growth 2015-2019, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Anti-epileptic Drugs for Pediatrics Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Anti-epileptic Drugs for Pediatrics Market Size 2015-2019, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table Anti-epileptic Drugs for Pediatrics Market Forecast 2020-2025, by Region, in USD Million

Table Anti-epileptic Drugs for Pediatrics Market Forecast 2020-2025, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

List of Table